TP53 and acute myeloid leukemia: While it has long been known that monosomal karyotype is adverse and often enriched in complex karyotype AMLs [4, 28] with frequent del(17p) [29], these cohorts comprised a heterogeneous mix of AML patients of all risk groups without specifically focusing on TP53-mutated individuals.